Monalisa Hard Dermal Filler

$28.90

Monalisa Hard Dermal Filler is a medical-grade hyaluronic acid injectable containing ​​24mg/ml cross-linked HA with 0.3% lidocaine​​. Clinically proven to deliver ​​89% improvement in glabellar lines​​ with ​​12-18 month longevity​​. Manufactured to ​​KGMP standards​​ with ​​<2% BDDE residues​​ for safe volumizing and contouring.

Bundle Your Faves, Boost Your Savings!
Mix-And-Match Quantity​ Get More Discount Final Price
5-154%$27.74
16-306%$27.17
31-Unlimited8%$26.59
Categories: ,
Description

Monalisa Hard Dermal Filler

Precision Treatment for Medium-Deep Facial Wrinkles & Lip Enhancement

Professional Grade Filler

Medical-grade hyaluronic acid dermal filler containing 24mg/ml cross-linked HA with 0.3% lidocaine. Clinically proven to deliver 89% improvement in glabellar lines (Phase III trials) with longevity of 12-18 months. KGMP-certified formulation exceeds EU Medical Device Directive 93/42/EEC standards with <2% BDDE residues and <0.5 EU/ml endotoxins for enhanced safety profile.

Key Advantages

Optimal HA Density

24mg/ml concentration for superior volume restoration

Integrated Anesthetic

0.3% lidocaine for enhanced patient comfort

Precision Delivery

1.0ml syringe with 25G/27G needles

Extended Stability

24-month shelf life at 2-25°C

Core Technology

HyaluroLock™ Cross-Linking

Patented cross-linking technology achieves optimal G-prime value (450-550Pa) for:

  • Volume maintenance lasting 12+ months
  • Natural tissue integration
  • Minimal swelling propensity

ISO 13485 Certified | <2% BDDE residues | <0.5 EU/ml endotoxins

Medical Packaging

Packaging Details

  • Batch-tracked sterile packaging
  • Pre-filled 1.0ml precision syringe

Storage Requirements

  • 2-25°C temperature stability
  • 24-month shelf life

Clinical Protocol

Injection Technique

  • Subcutaneous injection method
  • 30°-45° needle angle insertion
  • Retrograde linear threading technique

Dosage Guidelines

  • Maximum 0.2ml per injection pass
  • 25G/27G needle selection
  • Staged treatment approach recommended

⚠️ Contraindication: Not for use during pregnancy

Medical Practice Notice

For licensed practitioners only. Not FDA-approved. Adverse event rate: 0.37% in clinical trials (temporary erythema/swelling possible). Genoss Co. certifies compliance with ISO 9001:2015 (QMS) and ISO 13485:2016 (Medical Devices). Results vary based on injection technique and patient physiology. Batch-specific data available upon request.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Monalisa Hard Dermal Filler”
Review now to get coupon!

Your email address will not be published. Required fields are marked *

You have to be logged in to be able to add photos to your review.